Moderate dose-intensive chemotherapy for patients with non-small cell lung cancer: randomized trial, can it improve survival of patients with good performance status?

Oncology reports

Volumn 6, Issue 5, 1999, Pages 1045-1050

  Masutani, M ^a   Tsujino, I ^a   Fujie, T ^a   Yamaguchi, M ^a   Miyagi, K ^a   Yano, T ^a   Takahashi, N ^a   Koya, Y ^a   Horie, T ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; MITOMYCIN; VINDESINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; SURVIVAL ANALYSIS; VINDESINE;

EID: 0033192682     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.6.5.1045     Document Type: Article

References (0)